Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | Mr. Ian F. SmithExecutive Chair | 3,44k | 0,00 | Derivative Exercise and Retained Stock | - | 134,71k | 2,62% |
| 2026-03-11 | RA Capital Management, L.P.Unternehmen | 3,16M | 23,71M | Kauf | 7,28 - 7,79 | 8,83M | 55,61% |
| 2026-02-06 | RA Capital Management, L.P.Unternehmen | 354,94k | 2,30M | Kauf | 6,49 | 5,67M | 6,67% |
| 2026-02-13 | Mr. Alexander G. CumboPresident, CEO & Director | 13,39k | 0,00 | Derivative Exercise and Retained Stock | - | 235,41k | 6,03% |
| 2026-02-13 | Mr. Alexander G. CumboPresident, CEO & Director | -16,64k | 96,92k | Derivative Exercise and Sale | 5,82 | 235,41k | - |
| 2026-02-13 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | 3,99k | 0,00 | Derivative Exercise and Retained Stock | - | 74,32k | 5,67% |
| 2026-02-13 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | -4,13k | 24,07k | Derivative Exercise and Sale | 5,82 | 74,32k | - |
| 2026-02-13 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | 2,20k | 0,00 | Derivative Exercise and Retained Stock | - | 146,17k | 1,53% |
| 2026-02-13 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -2,66k | 15,48k | Derivative Exercise and Sale | 5,82 | 146,17k | - |
| 2026-02-13 | Mr. Paul HerzichCTO | 3,57k | 0,00 | Derivative Exercise and Retained Stock | - | 72,64k | 5,17% |
| 2026-02-13 | Mr. Paul HerzichCTO | -3,62k | 21,06k | Derivative Exercise and Sale | 5,82 | 72,64k | - |
| 2026-02-13 | Mr. David Tyronne HowtonCOO & Secretary | 7,22k | 0,00 | Derivative Exercise and Retained Stock | - | 105,08k | 7,38% |
| 2026-02-13 | Mr. David Tyronne HowtonCOO & Secretary | -7,47k | 43,49k | Derivative Exercise and Sale | 5,82 | 105,08k | - |
| 2026-02-13 | Dr. Gabriel BrooksChief Medical Officer | 5,37k | 0,00 | Derivative Exercise and Retained Stock | - | 89,47k | 6,39% |
| 2026-02-13 | Dr. Gabriel BrooksChief Medical Officer | -5,56k | 32,40k | Derivative Exercise and Sale | 5,82 | 89,47k | - |
| 2026-02-13 | Mr. Kevin TanCFO & Treasurer | 5,22k | 0,00 | Derivative Exercise and Retained Stock | - | 99,42k | 5,54% |
| 2026-02-13 | Mr. Kevin TanCFO & Treasurer | -5,40k | 31,47k | Derivative Exercise and Sale | 5,82 | 99,42k | - |
| 2026-02-04 | Mr. David Tyronne HowtonCOO & Secretary | -18,89k | 121,71k | Verkauf | 6,44 | 97,86k | -16,18% |
| 2026-02-04 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -7,21k | 46,41k | Verkauf | 6,44 | 143,96k | -4,77% |
| 2026-02-04 | Mr. Alexander G. CumboPresident, CEO & Director | -48,91k | 315,09k | Verkauf | 6,44 | 222,02k | -18,05% |
| 2026-02-04 | Mr. Kevin TanCFO & Treasurer | -14,78k | 95,23k | Verkauf | 6,44 | 94,20k | -13,56% |
| 2026-02-04 | Dr. Gabriel BrooksChief Medical Officer | -12,62k | 81,27k | Verkauf | 6,44 | 84,09k | -13,05% |
| 2026-02-04 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | -12,35k | 79,54k | Verkauf | 6,44 | 70,33k | -14,94% |
| 2026-02-04 | Mr. Paul HerzichCTO | -10,91k | 70,25k | Verkauf | 6,44 | 69,07k | -13,64% |
| 2026-01-29 | Mr. Kevin TanCFO & Treasurer | 62,88k | 0,00 | Derivative Exercise and Retained Stock | - | 108,98k | 136,41% |
| 2026-01-31 | Mr. Kevin TanCFO & Treasurer | -26,84k | 172,75k | Derivative Exercise and Sale | 6,44 | 108,98k | - |
| 2026-01-29 | Mr. Alexander G. CumboPresident, CEO & Director | 189,54k | 0,00 | Derivative Exercise and Retained Stock | - | 270,93k | 232,89% |
| 2026-01-31 | Mr. Alexander G. CumboPresident, CEO & Director | -80,26k | 516,61k | Derivative Exercise and Sale | 6,44 | 270,93k | - |
| 2026-01-29 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | 56,02k | 0,00 | Derivative Exercise and Retained Stock | - | 82,68k | 210,11% |
| 2026-01-31 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | -26,54k | 170,80k | Derivative Exercise and Sale | 6,44 | 82,68k | - |
| 2026-01-29 | Dr. Gabriel BrooksChief Medical Officer | 58,74k | 0,00 | Derivative Exercise and Retained Stock | - | 96,71k | 154,69% |
| 2026-01-29 | Dr. Gabriel BrooksChief Medical Officer | -28,34k | 182,39k | Derivative Exercise and Sale | 6,44 | 96,71k | - |
| 2026-01-29 | Mr. David Tyronne HowtonCOO & Secretary | 83,85k | 0,00 | Derivative Exercise and Retained Stock | - | 116,75k | 254,79% |
| 2026-01-31 | Mr. David Tyronne HowtonCOO & Secretary | -37,77k | 243,13k | Derivative Exercise and Sale | 6,44 | 116,75k | - |
| 2026-01-29 | Mr. Paul HerzichCTO | 53,35k | 0,00 | Derivative Exercise and Retained Stock | - | 79,97k | 200,40% |
| 2026-01-29 | Mr. Paul HerzichCTO | -26,25k | 168,97k | Derivative Exercise and Sale | 6,44 | 79,97k | - |
| 2026-01-31 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | 15,00k | 0,00 | Derivative Exercise and Retained Stock | - | 151,17k | 11,02% |
| 2026-01-27 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 136,17k | 3,09% |
| 2026-01-27 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -191,00 | 1,26k | Derivative Exercise and Sale | 6,59 | 136,17k | - |
| 2026-01-09 | Mr. Kevin TanCFO & Treasurer | 5,55k | 0,00 | Derivative Exercise and Retained Stock | - | 46,10k | 13,68% |
| 2026-01-09 | Mr. Kevin TanCFO & Treasurer | -5,70k | 30,06k | Derivative Exercise and Sale | 5,27 | 46,10k | - |
| 2026-01-06 | Mr. Ian F. SmithExecutive Chair | 4,57k | 0,00 | Derivative Exercise and Retained Stock | - | 131,26k | 3,61% |
| 2026-01-03 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | 1,94k | 0,00 | Derivative Exercise and Retained Stock | - | 132,09k | 1,49% |
| 2026-01-03 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -1,05k | 5,72k | Derivative Exercise and Sale | 5,43 | 132,09k | - |
| 2025-12-02 | Mr. David Tyronne HowtonCOO & Secretary | 8,12k | 0,00 | Derivative Exercise and Retained Stock | - | 32,91k | 32,75% |
| 2025-12-02 | Mr. David Tyronne HowtonCOO & Secretary | -4,93k | 25,20k | Derivative Exercise and Sale | 5,11 | 32,91k | - |
| 2025-12-02 | Mr. Alexander G. CumboPresident, CEO & Director | 17,80k | 0,00 | Derivative Exercise and Retained Stock | - | 81,39k | 28,00% |
| 2025-12-02 | Mr. Alexander G. CumboPresident, CEO & Director | -10,81k | 55,23k | Derivative Exercise and Sale | 5,11 | 81,39k | - |
| 2025-12-02 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | 7,38k | 0,00 | Derivative Exercise and Retained Stock | - | 26,66k | 38,27% |
| 2025-12-02 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | -4,48k | 22,91k | Derivative Exercise and Sale | 5,11 | 26,66k | - |
| 2025-12-02 | Mr. Paul HerzichCTO | 4,54k | 0,00 | Derivative Exercise and Retained Stock | - | 26,62k | 20,55% |
| 2025-12-02 | Mr. Paul HerzichCTO | -2,70k | 13,80k | Derivative Exercise and Sale | 5,11 | 26,62k | - |
| 2025-11-10 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -3,28k | 13,51k | Verkauf | 4,12 | 129,65k | -2,47% |
| 2025-10-18 | Dr. Gabriel BrooksChief Medical Officer | 6,86k | 0,00 | Derivative Exercise and Retained Stock | - | 33,82k | 25,42% |
| 2025-10-18 | Dr. Gabriel BrooksChief Medical Officer | -2,90k | 17,25k | Derivative Exercise and Sale | 5,96 | 33,82k | - |
| 2025-10-06 | Mr. Ian F. SmithExecutive Chair | 4,57k | 0,00 | Derivative Exercise and Retained Stock | - | 126,69k | 3,74% |
| 2025-06-16 | RA Capital Management, L.P.Unternehmen | 553,04k | 2,48M | Kauf | 4,31 - 4,50 | 5,67M | 10,80% |
| 2025-07-06 | Mr. Ian F. SmithExecutive Chair | 4,57k | 0,00 | Derivative Exercise and Retained Stock | - | 122,12k | 3,89% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
